Cp4 - Weighted Average Calculations for Populating Cost-Effectiveness Models: How Ignoring the Model’s Clinical Pathways Can Significantly Bias the Incremental Cost-Effectiveness Ratio (Icer)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.030
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search